Suresh Awale

Dr. Suresh Awale

University of Toyama
orcid

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2006 in Cancer Research
Verified
Journal Article
Closed access
PDF file
Suresh AwaleSuresh Awale
Suresh Awale
JLJie Lu
Jie Lu
SKSurya K. Kalauni
Surya K. Kalauni
YKYukiko Kurashima
Yukiko Kurashima
YTYasuhiro Tezuka
Yasuhiro Tezuka
HEHiroyasu Esumi
Hiroyasu Esumi
The intracellular and extracellular dynamics that govern tumor growth and invasiveness in vivo remain poorly understood. Cell genotype and phenotype, and nutrient, oxygen, and growth factor concentrations are key variables. In previous work, using a reaction-diffusion mathematical model based on variables that directly describe tumor cell cycle and biology, we formulated the hypothesis that tumor morphology is determined by the competition between heterogeneous cell proliferation caused by spatial diffusion gradients, e.g., of cell nutrients, driving shape instability and invasive tumor morphologies, and stabilizing mechanical forces, e.g., cell-to-cell and cell-to-matrix adhesion. To test this hypothesis, we here obtain variable-based statistics for input to the mathematical model from in vitro human and rat glioblastoma cultures. A linear stability analysis of the model predicts that glioma spheroid morphology is marginally stable. In agreement with this prediction, for a range of variable values, unbounded growth of the tumor mass and invasion of the environment are observed in vitro. The mechanism of invasion is recursive subspheroid component development at the tumor viable rim and separation from the parent spheroid. Results of computer simulations of the mathematical model closely resemble the morphologies and spatial arrangement of tumor cells from the in vitro model. We propose that tumor morphogenesis in vivo may be a function of marginally stable environmental conditions caused by spatial variations in cell nutrients, oxygen, and growth factors, and that controlling these conditions by decreasing spatial gradients could benefit treatment outcomes, whereas current treatment, and especially antiangiogenic therapy, may trigger spatial heterogeneity (e.g., local hypoxia), thus causing invasive instability. (Cancer Res 2006; 66(3): 1597-604)

1 January 2004 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
MNMai Thanh Thi Nguyen
Mai Thanh Thi Nguyen
Suresh AwaleSuresh Awale
Suresh Awale
YTYasuhiro Tezuka
Yasuhiro Tezuka
QTQuan Le Tran
Quan Le Tran
HWHiroshi Watanabe
Hiroshi Watanabe
SKShigetoshi Kadota
Shigetoshi Kadota
Among 288 extracts, prepared from 96 medicinal plants used in Vietnamese traditional medicine to treat gout and related symptoms, 188 demonstrated xanthine oxidase (XO) inhibitory activity at 100 μg/ml, with 46 having greater than 50% inhibition. At 50 μg/ml, 168 of the extracts were active, with 21 possessing more than 50% inhibition. At 25 μg/ml, 146 extracts exhibited inhibitory activity, with 8 showing over 50% inhibition, while 126 extracts presented activity at 10 μg/ml, with 2 having greater than 50% inhibition. The MeOH extracts of Artemisia vulgaris, Caesalpinia sappan (collected at the Seven-Mountain area), Blumea balsamifera (collected in Lam Dong province), Chrysanthemum sinense and MeOH–H2O extract of Tetracera scandens (Khanh Hoa province) exhibited strong XO inhibitory activity with IC50 values less than 20 μg/ml. The most active extract was the MeOH extract of the flower of C. sinense with an IC50 value of 5.1 μg/ml. Activity-guided fractionation of the MeOH extract led to the isolation of caffeic acid (1), luteolin (2), eriodictyol (3), and 1,5-di-O-caffeoylquinic acid (4). All these compounds showed significant XO inhibitory activity in a concentration-dependent manner, and the activity of 2 was more potent (IC50 1.3 μM) than the clinically used drug, allopurinol (IC50 2.5 μM).

1 January 2000 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Closed access
YTYasuhiro Tezuka
Yasuhiro Tezuka
PSPavlos Stampoulis
Pavlos Stampoulis
ABArjun H. Banskota
Arjun H. Banskota
Suresh AwaleSuresh Awale
Suresh Awale
KTKim Qui Tran
Kim Qui Tran
SKShigetoshi Kadota
Shigetoshi Kadota
From the MeOH extract of the aerial part of Vietnamese Orthosiphon stamineus, five new isopimarane-type diterpenes [orthosiphols F-J (1-5)] and two new diterpenes [staminols A (6) and B (7)] with a novel carbon-framework, to which we proposed the name "staminane", and three new highly-oxygenated staminane-type diterpenes [staminolactones A (8) and B (9) and norstaminol A (10)1 were isolated. Moreover, staminolactone A (8) is 8,14-secostaminane-type and staminolactone B (9) is 13,14-secostaminane-type, while norstaminol A (10) is 14-norstaminen-type. Together with these new diterpenes, sixteen known compounds were also isolated and identified to be: 7,3',4'-tri-O-methylluteolin (11), eupatorin (12), sinensetin (13), 5-hydroxy-6,7,3',4'-tetramethoxyflavone (14), salvigenin (15), ladanein (16), tetramethylscutellarein (17), 6-hydroxy-5,7,4'-trimethoxyflavone (18), vomifoliol (19), aurantiamide acetate (20), rosmarinic acid (21), caffeic acid (22), oleanolic acid (23), ursolic acid (24), betulinic acid (25), and beta-sitosterol (26). All the isolated compounds were tested for their cytotoxicity towards highly liver metastatic murine colon 26-L5 carcinoma cells, and the new diterpenes, except for 4, and flavonoids (11, 12, 16, 18) showed cytotoxicity with an ED50 value between 10 and 90 microg/ml.

1 May 2008 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
FLFeng Li
Feng Li
Suresh AwaleSuresh Awale
Suresh Awale
YTYasuhiro Tezuka
Yasuhiro Tezuka
SKShigetoshi Kadota
Shigetoshi Kadota

1 April 2002 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ABArjun H Banskota
Arjun H Banskota
TNTakema Nagaoka
Takema Nagaoka
LSLucia Yoshie Sumioka
Lucia Yoshie Sumioka
YTYasuhiro Tezuka
Yasuhiro Tezuka
Suresh AwaleSuresh Awale
Suresh Awale
SKShigetoshi Kadota
Shigetoshi Kadota

1 January 2008 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
Suresh AwaleSuresh Awale
Suresh Awale
FLFeng Li
Feng Li
HOHiroko Onozuka
Hiroko Onozuka
HEHiroyasu Esumi
Hiroyasu Esumi
YTYasuhiro Tezuka
Yasuhiro Tezuka
SKShigetoshi Kadota
Shigetoshi Kadota